Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Sertraline) - Pilot study.

Phase 4

Completed

• Conditions: Impulsivity Violence; Impulsivity; Violence; Mental Health - Other mental health disorders

• Registration Number: ACTRN12608000559314
• Lead Sponsor: SW Justice Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-11-07
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

Men
At least 1 prior conviction for violence
Score over 70 on an impulsivity screener

Exclusion Criteria

Current medications include a Selective Serotonin Reuptake Inhibitor (SSRI) or other antidepressant (especially a Mono Amine Oxidase Inhibitor) or anti-psychotics.
Severe mental illness.
History of adverse drug reactions to a Selective Serotonin Reuptake Inhibitor (SSRI).
Past conviction for murder, manslaughter or sexual assault.
Regular use of amphetamine.
From remote/inaccessible area.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Impulsive behaviour as measured on the Barratt Impulsiveness Scale.[1 month & 3 months]

Secondary Outcome Measures

Name	Time	Method
Depression (Beck Depression Inventory)[1 month & 3 months];Psychological distress (Kessler Psychological distress Scale - K10)[1 month & 3 months];Aggressive behaviour (Anger, Irritability, Aggression Questionnaire - AIAQ)[1 month & 3 months]